医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Quintiles Named a Best Workplace in South Korea

2014年11月19日 PM01:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Quintiles announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to receive the award; it joins many other Quintiles’ offices worldwide similarly honoured by the Great Place to Work Institute.

Quintiles Korea was a “Grand Award” winner – the highest level – from among more than 100 companies in South Korea that participated in this year’s study. The Great Place to Work Institute annual ranking is a comprehensive study of organizational culture and also the world’s largest and most respected study of workplace excellence and people management practices.

MiSook Hyun, General Manager of Quintiles Korea, said: “This award affirms our efforts to create a company that employees can trust and that values their well-being. It is a tremendous honor and speaks volumes about Quintiles’ commitment to our people.

“We are incredibly proud of our team in South Korea and the work they do to improve our customers’ probability of success. It’s wonderful to see our efforts to create a positive, collaborative workplace validated by this award.”

The Great Place to Work Institute launched the first Best Companies to Work For list in conjunction with Fortune magazine in the United States and Exame in Brazil more than 20 years ago. The institute now recognises great workplaces in nearly 50 countries.

Won Wook Ji, executive director of Great Place to Work® Korea, said: “Employee trust is not only a measure of evaluation but also the foundation of a company’s success. It is important for companies to create workplaces dedicated to fostering trust, pride and camaraderie amongst their employees, in addition to ongoing trust with customers.

“In that sense, it is meaningful for Quintiles Korea to be selected as a 2014 Great Place to Work. It is not overstating that the future of business in Korea rests on these great companies to work for.”

About Quintiles

Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Click here to subscribe to Mobile Alerts for Quintiles.

CONTACT

Quintiles
Media Relations:
Jessie Lee, +65.8181.3805
jessie.lee@quintiles.com
or
Investor
Relations:
Karl Deonanan, +1-919-998-2789
InvestorRelations@quintiles.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
  • Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
  • クリアがCOVID-19声明に関する政府の訴訟に対して修正答弁書を提出、クリア製品の追加防御層としての使用を支持するデータをさらに提供
  • Integral Group Australia Rebranding as Introba to Align with Global Brands
  • 针对政府就新冠病毒声明提起的诉讼,Xlear提交修正后的答复;通过更多数据继续支持Xlear作为额外防护层使用